Article citationsMore>>

S. J. A. Gold and N. J. N. Harper, “The Place of Sugammadex in Anaesthesia Practice,” Trends in Anaesthesia and Critical Care, Vol. 2, No. 1, 2012, pp. 4-9.

has been cited by the following article:

• TITLE: Successful Use of Sugammadex in a Myasthenic Patient Case Report

  AUTHORS: Silvia Kangassu Rios, Daiana Gomes, Marcos Lopes De Miranda, Carlos Frederico La Cava, Carlos Darcy Bersot

  KEYWORDS: Sugammadex; Myasthenia Gravis; Rocuronium; Neuromuscular Monitoring; Anesthesia

  JOURNAL NAME: Open Journal of Anesthesiology, Vol.3 No.1, January 31, 2013

  ABSTRACT: The Myasthenia gravis (MG) is an autoimmune disease that affects neuromuscular transmission and leads to a large variation of sensibility on depolarizing and nondepolarizing neuromuscular blocking drugs. Sugammadex is a new drug with the capability to successfully revert the nondepolarizing neuromuscular blocking. This case report will show a patient with MG that was scheduled for thymectomy, with the objective to use sugammadex to reverse a rocuronium induced deep level of neuromuscular block and observing the safe use of sugammadex without complications.